S597 Continuous Integration of 2024 Colonoscopy Quality Metrics into Practice: An Updated Quality Improvement Project

Le résumé fourni par la source

Introduction: Colonoscopy quality indicators continue to evolve with emerging data and technological advances. This quality improvement (QI) project aimed to integrate the updated 2024 colonoscopy metric guidelines into our daily practice. Whereas previous guidelines focused solely on average-risk screening colonoscopies, the new recommendations expand quality tracking to all colonoscopies, regardless of indication. We evaluated the impact of this broadened scope on key performance metrics. Methods: The project began with a comprehensive review of the 2024 guideline updates, followed by staff education and training on new benchmark metrics. Revised indicators were implemented with ongoing monthly tracking and analysis using descriptive statistics. Measured metrics included Adenoma Detection Rate (ADR), Adenomas Per Colonoscopy (APC), Sessile Serrated Lesion Detection Rate (SSLDR), and Withdrawal Time. Results: A total of 860 colonoscopies performed from October 2024 to April 2025 were compared to 1,456 procedures from the prior fiscal year (October 2023–September 2024). ADR increased from 58.5% to 64.3%, SSLDR rose from 11.2% to 12.3%, and APC improved from 1.59 to 2.13. Mean withdrawal time increased from 13.3 to 14.65 minutes. Conclusion: The 2024 guideline updates broaden the scope of colonoscopy quality metrics to include all indications (with select exceptions), reinforcing the importance of comprehensive quality assessment in reducing colorectal cancer risk. Integration of these metrics into our practice demonstrates improved detection outcomes and highlights the value of continuous monitoring. As time progresses it is important to reevaluate metrics to ensure continued high-quality procedures.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.